Drug Type Small molecule drug |
Synonyms FAUN 1083, FAUN1083, FB-1083 |
Target |
Action antagonists |
Mechanism Faun269g antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart failure with normal ejection fraction | Preclinical | United States | 01 Nov 2025 | |
| Hypertension, Pulmonary | Preclinical | United States | 01 Nov 2025 |





